Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Women's He...(://www.health.harvard.edu/women target ...),Health
Navigation Links
Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Women's Health Watch
Date:2/7/2008
://www.health.harvard.edu/women" target="_new">http://www.health.harvard.edu/women or by calling 877-649-9457 (toll-free).
Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.
'/>"/>
| SOURCE Harvard Women's Health Watch Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes
2. News Flash on Hot Flashes: Soy Can Turn Down the Heat
3. From Hot Flashes to Breast Cancer: ZRT Labs Hormone Testing Catches On As Women Consider Safer, More Natural Options.
4. Flaxseed May Relieve Hot Flashes
5. Tonsillectomy Not Always Cost-Effective for Kids Throat Woes
6. Some Epilepsy Patients Not Always Aware of Seizures
7. Announcing Always Best Care Senior Services Expansion Into the Granada Hills/Sherman Oaks, California Areas
8. Announcing Always Best Care Senior Services Expansion Into Cleveland, Ohio
9. Announcing Always Best Care Senior Services Expansion into Santa Barbara, California
10. Announcing Always Best Care Senior Services Expansion Into San Diego, California
11. Announcing Always Best Care Senior Services Expansion into Colorado Springs, Colorado
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 2Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 2Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 4Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 2Health News:Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn 3Health News:Sticks and stones break bones, but this UH study may prevent it 2Health News:Potential New Target Found for Alzheimer's Disease 2
[0] Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report[0] Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity[0] Nerve-cell transplants help brain-damaged rats fully recover lost ability to learn[0] Sticks and stones break bones, but this UH study may prevent it[0] Potential New Target Found for Alzheimer's Disease
Other Medicine News:Health News:SARS Patients Experience Mental Health Decline 2Health News:Doctor Migration Has Limited Impact on Health Care in Poor Countries: OECD 2Health News:Street-protesting Polish Nurses Threaten to Stay Put 2Health News:Heart Care for Disadvantaged Children With American Help 2Health News:Drug Firms Sue British Regulator Over Alzheimer's Drugs 2
SARS Patients Experience Mental Health DeclineDoctor Migration Has Limited Impact on Health Care in Poor Countries: OECDStreet-protesting Polish Nurses Threaten to Stay PutAfghan Refugee Gives Birth to Quintuplets in PakistanHeart Care for Disadvantaged Children With American HelpDrug Firms Sue British Regulator Over Alzheimer's Drugs
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 1COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 2Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 1Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4
[0] Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine[0] Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix[0] Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
Other Medicine Technology:Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis 2Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis 3Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |